Publications by authors named "Claudio Catalani"

Claim this Profile
A
Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation.
Erika Terzuoli, Stefania Meini, Paola Cucchi, Claudio Catalani, Cecilia Cialdai

PLoS One· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of ibodutant at NK(2) receptor in human colon.
Paolo Santicioli, Stefania Meini, Sandro Giuliani, Claudio Catalani, Paolo Bechi

Eur J Pharmacol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioligand binding characterization of the bradykinin B(2) receptor in the rabbit and pig ileal smooth muscle.
Stefania Meini, Paola Cucchi, Claudio Catalani, Francesca Bellucci, Paolo Santicioli

Eur J Pharmacol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of the bradykinin B2 receptor antagonist MEN16132 in rat in vitro bioassays.
Stefania Meini, Paola Cucchi, Claudio Catalani, Francesca Bellucci, Sandro Giuliani

Eur J Pharmacol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifaceted approach to determine the antagonist molecular mechanism and interaction of ibodutant ([1-(2-phenyl-1R-[[1-(tetrahydropyran-4-ylmethyl)-piperidin-4-ylmethyl]-carbamoyl]-ethylcarbamoyl)-cyclopentyl]-amide) at the human tachykinin NK2 receptor.
Stefania Meini, Francesca Bellucci, Claudio Catalani, Paola Cucchi, Alessandro Giolitti

J Pharmacol Exp Ther· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cecilia Cialdai, Manuela Tramontana, Riccardo Patacchini, Alessandro Lecci, Claudio Catalani

Eur J Pharmacol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
Paola Cucchi, Stefania Meini, Alessandro Bressan, Claudio Catalani, Francesca Bellucci

Eur J Pharmacol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor.
Stefania Meini, Claudio Catalani, Francesca Bellucci, Paola Cucchi, Sandro Giuliani

Eur J Pharmacol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological evaluation of alpha and beta human tachykinin NK(2) receptor splice variants expressed in CHO cells.
Francesca Bellucci, Stefania Meini, Rose-Marie Catalioto, Claudio Catalani, Sandro Giuliani

Eur J Pharmacol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Francesca Bellucci, Stefania Meini, Paola Cucchi, Claudio Catalani, Sandro Giuliani

Eur J Pharmacol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutagenesis at the human tachykinin NK(2) receptor to define the binding site of a novel class of antagonists.
Stefania Meini, Francesca Bellucci, Claudio Catalani, Paola Cucchi, Riccardo Patacchini

Eur J Pharmacol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-directed mutagenesis at the human B2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonists.
Stefania Meini, Paola Cucchi, Francesca Bellucci, Claudio Catalani, Angela Faiella

Biochem Pharmacol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A different molecular interaction of bradykinin and the synthetic agonist FR190997 with the human B2 receptor: evidence from mutational analysis.
Francesca Bellucci, Stefania Meini, Paola Cucchi, Claudio Catalani, Wolfgang Reichert

Br J Pharmacol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.
Francesca Bellucci, Francesca Carini, Claudio Catalani, Paola Cucchi, Alessandro Lecci

Br J Pharmacol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis